AFFYMETRIX (AFFX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AFFYMETRIX (AFFX)

AFFX 14.01

0.0%

Apr 1 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (1560)	6/13/2002 12:07:28 PM
From: nigel bates	Read Replies (1) of 1728

Standard blurb from past PRs - Affymetrix' EasyAccess™ packages are volume access arrangements designed to meet the needs of large research organizations that want preferential and broad access to Affymetrix' GeneChip technology... I did find one 'Gold' customer <g> - In exchange for supplying Hoechst Marion Roussel with its GeneChip technology, Affymetrix will receive an annual subscription fee, custom design fees and per chip fees according to the Company's EasyAccess-Gold technology program. These payments are expected to exceed $15 million over the initial three years of the agreement... nig

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next